MedTrace Logo

STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk

NCT01442896 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2024-01-23

No results posted yet for this study

Summary

The purpose of this study is to perform exploratory analyses to evaluate rates of functional and structural change in glaucoma, to identify predictors of rapid progression in patients with glaucoma and to identify possible genetic factors and biomarkers associated with the disease.

Conditions

  • Primary Open Angle Glaucoma

Sponsors & Collaborators

Principal Investigators

  • Robert Weinreb, MD · UCSD Shiley Eye Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-01
Primary Completion
2015-12-18
Completion
2015-12-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01442896 on ClinicalTrials.gov